STOCK TITAN
  1. Home
  2. News
  3. MDRX

Veradigm - MDRX STOCK NEWS

Welcome to our dedicated page for Veradigm news (Ticker: MDRX), a resource for investors and traders seeking the latest updates and insights on Veradigm stock.

Veradigm Inc. (NASDAQ: MDRX) is a prominent player in the healthcare information technology sector, dedicated to enhancing clinical, financial, and operational results through innovative IT solutions. The company's core business revolves around creating an expansive, open, and connected community of health, which bridges the gaps between people, places, and data. This connectivity is pivotal in empowering caregivers to make informed decisions and deliver superior care, ultimately leading to healthier populations.

Veradigm's comprehensive suite of solutions includes electronic health records (EHR), practice management systems, revenue cycle management, and patient engagement tools. These products are meticulously designed to streamline healthcare operations, improve patient outcomes, and navigate the evolving landscape of healthcare delivery.

Recently, Veradigm has faced significant changes. The company was replaced in the S&P SmallCap 600 by Sprinklr Inc. (NYSE: CXM) and was suspended from the NASDAQ Stock Market effective February 29, 2024, due to non-compliance with NASDAQ listing rules. Despite these challenges, Veradigm continues to innovate and adapt, focusing on delivering value through their cutting-edge technology solutions.

Veradigm's commitment to connectivity extends to their robust partnerships and collaborations. These alliances enhance their ability to offer integrated solutions that meet the dynamic needs of the healthcare sector. Veradigm's financial condition and strategic initiatives reflect their dedication to maintaining leadership in the healthcare IT domain.

For more details and the latest updates on Veradigm Inc., visit their official website or follow their social media channels on Twitter, YouTube, and their blog.

News

Veradigm Selects MedAllies as its Qualified Health Information Network™ (QHIN™ ) Partner

Rhea-AI Summary
MedAllies (NASDAQ: MDRX) partners with Veradigm Inc. to improve interoperability and treatment decisions for healthcare providers using Veradigm's EHRs. The partnership aims to provide access to longitudinal patient records, medical history, and medication lists, resulting in better point-of-care decision-making and improved interoperability throughout the healthcare industry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.01%
Tags
none
-
News

Veradigm Leadership Team to Present at J.P. Morgan Healthcare Conference

Rhea-AI Summary
Veradigm Inc. (MDRX) to present at the 42nd Annual J.P. Morgan Healthcare Conference, providing an update on business and growth strategy.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.41%
Tags
management conferences
-
News

Veradigm Strengthens Award-Winning Revenue Cycle Services Portfolio with Acquisition of Full-Service RCM Company

Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) announces the acquisition of Koha Health, a full-service revenue cycle management company, to enhance its revenue cycle services portfolio in the ambulatory healthcare market. The acquisition brings Musculoskeletal Medicine specialty expertise and the ability to deliver revenue cycle services to ambulatory healthcare provider practices and ambulatory surgical centers utilizing various electronic health record systems.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.21%
Tags
acquisition
News

Veradigm Inc. Announces that Nasdaq Hearings Panel has Granted its Continued Listing, Pending Return to Compliance with Nasdaq Filing Requirements

Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) received a decision from the Nasdaq Hearings Panel granting its request for continued listing on the Nasdaq Capital Market, subject to compliance with Nasdaq Listing Rule 5250(c)(1) by February 27, 2024, and other conditions. The company remains noncompliant due to the non-filing of its Annual Report on Form 10-K for 2022 and Quarterly Reports on Form 10-Q for 2023. The Panel Decision has no immediate effect on the listing of the company’s common stock on the Nasdaq Global Select Market.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.1%
Tags
none
-
News

Veradigm to Enhance Independent Practice Financial Management with AI for Practice Fusion Billing Services

Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) announced the launch of a conversational AI agent for Practice Fusion Billing Services, aimed at simplifying the billing process and optimizing financial management for independent healthcare providers. The AI, integrated with Microsoft and Zammo.ai software, provides instant conversation responses and feedback, trained in a closed system to generate real-time responses based on a comprehensive billing knowledge base.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.4%
Tags
AI
-
News

Veradigm Inc. Announces Leadership Transition

Rhea-AI Summary
Veradigm Inc. (Nasdaq: MDRX) announced the appointment of Greg Garrison as Executive Chairman, Dr. Shih-Yin Ho as interim CEO, and Lee Westerfield as interim CFO. These changes are a result of an ongoing independent investigation related to financial reporting and internal controls. The company aims to strengthen its financial control environment and enhance financial reporting policies.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-20.02%
Tags
management
News

Veradigm Inc. Receives Nasdaq Notice Regarding Delayed Form 10-Q

Rhea-AI Summary
Veradigm Inc. (Nasdaq: MDRX) received a notice from Nasdaq indicating noncompliance with filing periodic reports. The company remains noncompliant with Nasdaq Listing Rule 5250(c)(1) due to the delay in filing the Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The company previously received notices from Nasdaq and is appealing the delisting notice. The noncompliance has no immediate effect on the company's stock listing, but the final decision regarding delisting is pending.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.96%
Tags
none
-
News

Veradigm to Simplify Patient Payment Journey with Veradigm Intelligent Payments

Rhea-AI Summary
Veradigm, Inc. (NASDAQ: MDRX) Announces New Solution 'Veradigm Intelligent Payments' to Digitally Engage with Patients, Improve Practice Efficiency, and Increase Payment Rates
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.56%
Tags
none
-
News

Veradigm Inc. Announces Receipt of Nasdaq Stay Extension

Rhea-AI Summary
Veradigm Inc. (NASDAQ: MDRX) received an extension on the temporary stay of delisting of its common stock pending a hearing before the Nasdaq Hearings Panel on November 16, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
none
News

Veradigm Joins FDB Vela ePrescribing Network to Offer Prescribers & Patients Greater Choice, Cost Transparency

Rhea-AI Summary
Veradigm joins FDB Vela ePrescribing network, expanding pharmacy connectivity
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.22%
Tags
none

FAQ

What is the current stock price of Veradigm (MDRX)?

The current stock price of Veradigm (MDRX) is $5 as of February 25, 2025.

What is the market cap of Veradigm (MDRX)?

The market cap of Veradigm (MDRX) is approximately 807.3M.

What is Veradigm Inc.?

Veradigm Inc. is a leading provider of healthcare information technology solutions aimed at improving clinical, financial, and operational outcomes.

What type of products does Veradigm offer?

Veradigm offers a range of products including electronic health records (EHR), practice management systems, revenue cycle management, and patient engagement tools.

Why was Veradigm suspended from the NASDAQ Stock Market?

Veradigm was suspended from the NASDAQ Stock Market due to non-compliance with NASDAQ listing rules as of February 29, 2024.

Who replaced Veradigm in the S&P SmallCap 600 index?

Sprinklr Inc. (NYSE: CXM) replaced Veradigm in the S&P SmallCap 600 index effective March 4, 2024.

What distinguishes Veradigm’s healthcare solutions?

Veradigm’s solutions are distinguished by their ability to connect people, places, and data, which empowers caregivers to make better decisions and improve patient care.

Where can I find more information about Veradigm?

More information about Veradigm can be found on their official website, Twitter, YouTube, and their blog.

What is the primary focus of Veradigm’s technology?

Veradigm's technology focuses on creating an open, connected community of health that enhances interoperability and data sharing in healthcare.

How does Veradigm support healthcare providers?

Veradigm supports healthcare providers by offering tools that streamline operations, improve patient outcomes, and facilitate effective decision-making.
Stock MDRX logo
Veradigm

Nasdaq:MDRX

MDRX Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

MDRX Stock Data

807.30M
105.42M
1.12%
22.77%
Health Information Services
Healthcare
Link
United States
Chicago